Related Experiment Video
Updated: Jun 28, 2026

09:38
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Continuous flow system for the evaluation of the extrinsic coagulation pathway
Talanta
|September 1, 1996
Summary
A new flow injection method reliably measures the extrinsic coagulation pathway by monitoring clot formation. This technique accurately assesses fibrin clotting capacity in human plasma for clinical diagnostics.
Area of Science:
- Biochemistry
- Clinical Chemistry
- Analytical Chemistry
Background:
- The extrinsic coagulation pathway is crucial for hemostasis.
- Accurate evaluation of coagulation factors is essential for diagnosing bleeding disorders.
- Existing methods may have limitations in speed or precision.
Purpose of the Study:
- To develop a simple and reliable method for evaluating the extrinsic coagulation pathway.
- To utilize a flow injection system for real-time monitoring of coagulation.
- To assess the clinical utility of the developed method for fibrin clotting capacity determination.
Main Methods:
- Developed a flow injection system using merging-zones and stopped-flow modes.
- Monitored the final step of coagulation photometrically at 340 nm.
- Measured clotting reaction rates based on the activity of coagulation factors.
Main Results:
- Established a linear range of 10-100% for total clottable activity.
- Achieved a relative standard deviation between 0.9% and 2.8%.
- Demonstrated excellent agreement with a conventional automated nephelometric method.
Conclusions:
- The developed flow injection method provides a simple, reliable, and accurate means for evaluating the extrinsic coagulation pathway.
- The method is suitable for determining fibrin clotting capacity in human plasma from both healthy and diseased individuals.
- This technique offers a valuable tool for clinical diagnostics and coagulation research.
More Related Videos
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

